Philip J.S. Charlesworth

Royal Berkshire NHS Foundation Trust, Age UK

Papers

2

Total Citations

325

H-Index

2

About

Philip J.S. Charlesworth is a leading urologic surgeon and researcher whose work centers on optimizing surgical outcomes for bladder cancer, particularly through the comparative effectiveness of robotic and open radical cystectomy. His most impactful contribution is the landmark 2022 study, cited over 320 times, which rigorously compared robot-assisted radical cystectomy with intracorporeal urinary diversion to open surgery, demonstrating significant improvements in 90-day morbidity and recovery. This work has been instrumental in guiding the global shift toward minimally invasive techniques. Charlesworth also explores innovative preoperative risk stratification, as seen in his 2020 study on wearable devices and cardiopulmonary exercise testing (CPET) to predict major complications. By integrating real-world mobility data with physiological assessments, he pioneers more personalized, data-driven surgical planning. His research not only advances surgical technique but also redefines how we evaluate patient fitness, making him a key figure in evidence-based urologic oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
325
Total Citations
163
Avg Citations/Paper
🏆 Most Cited Paper
Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer
320 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 72
🏛 Institutions: Royal Berkshire NHS Foundation Trust, Age UK

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago